Statistical power in clinical trials
In a new debate published in BMC Medicine, Peter Bachetti talks about the concept of statistical power in determining sample size, the undue weight that is… Read more »
In a new debate published in BMC Medicine, Peter Bachetti talks about the concept of statistical power in determining sample size, the undue weight that is… Read more »
In the developed world, we generally tend to take pain treatment and management for granted; if we’re in physical pain, someone will provide treatment to do… Read more »
As the era of personalised medicine and genomics evolves and the potential for better targeted treatments becomes a reality, the need to identify which… Read more »
If you’re like me, you probably know at least one person affected by multiple sclerosis, an autoimmune demyelinating disease of the central nervous system… Read more »
If you’re like me, you probably know at least one person affected by multiple sclerosis, an autoimmune demyelinating disease of the central nervous system… Read more »
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia affecting about 1% of the general population. Treatments such as rate controlling therapy… Read more »
Migraine is a largely inherited neurological disorder leading to a combination of symptoms including headache, visual and aural effects. As any long-time… Read more »
Several members of the BioMed Central Editorial team had the pleasure of attending the annual conference held by the National Cancer Research Institute (NCRI)… Read more »
In June 2009, BMC Medicine received its first “official” impact factor from Thomson Reuters of 3.28. To mark this landmark occasion, the BMC Medicine… Read more »
When will the next wave of influenza A (H1N1) or “swine flu” infections occur, how quickly will they spread, and are there dangers of new emerging human… Read more »